The Experts below are selected from a list of 33690 Experts worldwide ranked by ideXlab platform
Susan E. Dorman - One of the best experts on this subject based on the ideXlab platform.
-
quantiferon tb gold in tube implementation for latent tuberculosis diagnosis in a Public Health Clinic a cost effectiveness analysis
BMC Infectious Diseases, 2012Co-Authors: Maunank Shah, Danielle Dipietro, Maria Martinsevora, Vincent Marsiglia, Kathryn Miele, Howard Choi, Susan E. DormanAbstract:Background The tuberculin skin test (TST) has limitations for latent tuberculosis infection (LTBI) diagnosis in low-prevalence settings. Previously, all TST-positive individuals referred from the community to Baltimore City Health Department (BCHD) were offered LTBI treatment, after active TB was excluded. In 2010, BCHD introduced adjunctive QuantiFERON-TB Gold In-Tube (QFT-GIT) testing for TST-positive referrals. We evaluated costs and cost-effectiveness of this new diagnostic algorithm.
-
programmatic impact of quantiferon tb gold in tube implementation on latent tuberculosis diagnosis and treatment in a Public Health Clinic
PLOS ONE, 2012Co-Authors: Maunank Shah, Danielle Dipietro, Adena Greenbaum, Sherry Ketemepi, Maria Martinsevora, Vincent Marsiglia, Susan E. DormanAbstract:Background QuantiFERON-TB Gold In-Tube (QFT-GIT) is considered an alternative to the tuberculin skin test (TST) for the diagnosis of tuberculosis (TB) infection, but the programmatic impact of QFT-GIT implementation is largely unknown. In March, 2010, the Baltimore City Health Department (BCHD) introduced routine QFT-GIT testing for individuals referred to the TB program for suspected latent TB infection (LTBI).
-
timing of therapy for latent tuberculosis infection among immigrants presenting to a u s Public Health Clinic a retrospective study
BMC Public Health, 2008Co-Authors: Kathleen R Page, Yukari C Manabe, Akintoye Adelakun, Lynn Federline, Wendy Cronin, James D Campbell, Susan E. DormanAbstract:Background In the U.S. more than half of incident tuberculosis (TB) cases occur in immigrants. Current guidelines recommend screening and treatment for latent TB infection (LTBI) within 5 years of arrival to the U.S. This study evaluates the timing of LTBI therapy among immigrants presenting for care to a Public Health TB Clinic.
Kathleen R Page - One of the best experts on this subject based on the ideXlab platform.
-
Public Health Clinic based hepatitis c testing and linkage to care in baltimore
Journal of Viral Hepatitis, 2016Co-Authors: Oluwaseun Faladenwulia, Shruti H Mehta, J Lasola, Carl A Latkin, A Niculescu, C Oconnor, Patrick Chaulk, Khalil G Ghanem, Kathleen R Page, Mark S SulkowskiAbstract:Testing and linkage to care are important determinants of hepatitis C virus (HCV) treatment effectiveness. Public Health Clinics serve populations at high risk of HCV. We investigated their potential to serve as sites for HCV testing, initiation of and linkage to HCV care. Cross-sectional study of patients accessing sexually transmitted infection (STI) care at the Baltimore City Health Department (BCHD) STI Clinics, from June 2013 through April 2014 was conducted. Logistic regression was used to assess factors associated with HCV infection and specialist linkage to care. Between 24 June 2013 and 15 April 2014, 2681 patients were screened for HCV infection. Overall, 189 (7%) were anti-HCV positive, of whom 185 (98%) received follow-up HCV RNA testing, with 155 (84%) testing RNA positive. Of 155 RNA-positive individuals, 138 (89%) returned to the STI Clinic for HCV RNA results and initial HCV care including counselling regarding transmission and harm reduction in alcohol, and 132 (85%) were referred to a specialist for HCV care. With provision of patient navigation services, 81 (52%) attended an offsite HCV specialist appointment. Alcohol use and lack of insurance coverage were associated with lower rates of specialist linkage (OR 0.4 [95% CI 0.1-0.9] and OR 0.4 [95% CI 0.1-0.9], respectively). We identified a high prevalence of HCV infection in BCHD STI Clinics. With availability of patient navigation services, a large proportion of HCV-infected patients linked to off-site specialist care.
-
timing of therapy for latent tuberculosis infection among immigrants presenting to a u s Public Health Clinic a retrospective study
BMC Public Health, 2008Co-Authors: Kathleen R Page, Yukari C Manabe, Akintoye Adelakun, Lynn Federline, Wendy Cronin, James D Campbell, Susan E. DormanAbstract:Background In the U.S. more than half of incident tuberculosis (TB) cases occur in immigrants. Current guidelines recommend screening and treatment for latent TB infection (LTBI) within 5 years of arrival to the U.S. This study evaluates the timing of LTBI therapy among immigrants presenting for care to a Public Health TB Clinic.
-
improved adherence and less toxicity with rifampin vs isoniazid for treatment of latent tuberculosis a retrospective study
JAMA Internal Medicine, 2006Co-Authors: Kathleen R Page, Lynn Federline, Wendy Cronin, Frangiscos Sifakis, Ruben Montes De Oca, Meg C Doherty, Sarah Bur, Thomas J Walsh, Walter Karney, James MilmanAbstract:Background Treatment of latent tuberculosis infection (LTBI) is an important aspect of tuberculosis control in the United States, but the effectiveness of this strategy is compromised by poor adherence to the recommended 9-month isoniazid regimen. In this study, we compared treatment completion and Clinically recognized adverse drug reactions in patients prescribed 9 months of isoniazid therapy or 4 months of rifampin therapy for LTBI. Methods Retrospective chart review of patients who received LTBI treatment at a Public Health Clinic. Results A total of 770 patients were prescribed 9 months of isoniazid therapy, and 1379 patients were prescribed 4 months of rifampin therapy. The percentages of patients who completed 80% or more of their prescribed treatment were 52.6% and 71.6% in the isoniazid and rifampin groups, respectively ( P P P Conclusions Compared with a 9-month isoniazid regimen, a 4-month rifampin regimen was associated with a higher percentage of patients completing treatment and a lower percentage of patients with Clinically recognized adverse reactions. Additional studies are warranted to determine efficacy and effectiveness of rifampin therapy for LTBI.
Tony Kuo - One of the best experts on this subject based on the ideXlab platform.
-
knowledge attitudes and beliefs about seasonal influenza and h1n1 vaccinations in a low income Public Health Clinic population
Vaccine, 2012Co-Authors: Matthew D Redelings, Jennifer Piron, Lisa V Smith, Amy Chan, Julia Heinzerling, Kathleen M Sanchez, Dalia Bedair, Mirna Ponce, Tony KuoAbstract:Abstract Objective The Public Health Center Vaccine Survey (PHCVS) examines the knowledge, attitudes, and beliefs about seasonal influenza and H1N1 vaccinations in a largely low-income, urban, Public Health Clinic population in Los Angeles County, USA. Design A cross-sectional survey of vulnerable individuals at risk for severe influenza infection was conducted in one of the nation's largest local Public Health jurisdictions. Subjects A total of 1541 Clinic patients were recruited in the waiting rooms of five large Public Health centers in Los Angeles County from June to August, 2010. Results Among prospective respondents who met eligibility criteria, 92% completed the survey. The majority was black or Latino and most were between the ages of 18 and 44 years. More than half were unemployed; two-thirds had no Health insurance; and nearly one-half reported having a high school education or less. About one-fifth reported they had received the H1N1 vaccine during the previous flu season. In comparative analyses, negative beliefs about vaccine safety and efficacy were highly predictive of H1N1 vaccination. Blacks were less likely than non-black respondents to report receiving the H1N1 vaccine (OR = 0.7, 95% CI = 0.6–1.0). Blacks were also less likely than other respondents to agree that vaccines can prevent disease (OR = 0.4, 95% CI = 0.3–0.5), that vaccines are safe (OR = 0.5, 95% CI = 0.4–0.6), and that they trust doctors/Clinicians who recommend vaccines (OR = 0.5, 95% CI = 0.4–0.7). Conclusions Study findings provide a useful risk profile of vulnerable groups in Los Angeles County, which may be generalizable to other urban jurisdictions in the United States. They also describe real world situations that can be used to forecast potential challenges that vaccine beliefs may pose to national as well as local influenza pandemic planning and response, especially for communities with limited access to these preventive services.
-
knowledge attitudes and potential response to menu labelling in an urban Public Health Clinic population
Public Health Nutrition, 2010Co-Authors: Jennifer Piron, Lisa V Smith, Paul A Simon, Patricia L Cummings, Tony KuoAbstract:Objective The present study examines the receptivity to and potential effects of menu labelling on food choices of low-income and minority individuals - a group often at disproportionate risk for preventable, lifestyle-related Health conditions (e.g. obesity, diabetes and CVD). Design We conducted a cross-sectional survey to examine the knowledge, attitudes and potential response to menu labelling in an urban Public Health Clinic population. Setting United States. Subjects A total of 639 Clinic patients were recruited in the waiting rooms of six, large Public Health centres in Los Angeles County (2007-2008). These centres provide services to a largely uninsured or under-insured, low-income, Latino and African-American population. Results Among those approached and who met eligibility criteria, 88 % completed the survey. Of the 639 respondents, 55 % were overweight or obese based on self-reported heights and weights; 74 % reported visiting a fast food restaurant at least once in the past year, including 22 % at least once a week; 93 % thought that calorie information was 'important'; and 86 % thought that restaurants should be required to post calorie information on their menu boards. In multivariate analyses, respondents who were obese, female, Latino and supportive of calorie postings were more likely than others to report that they would choose food and beverages with lower calories as a result of menu labelling. Conclusions These findings suggest that Clinic patients are receptive to this population-based strategy and that they would be inclined to change their food selections in response to menu labelling.
Maunank Shah - One of the best experts on this subject based on the ideXlab platform.
-
quantiferon tb gold in tube implementation for latent tuberculosis diagnosis in a Public Health Clinic a cost effectiveness analysis
BMC Infectious Diseases, 2012Co-Authors: Maunank Shah, Danielle Dipietro, Maria Martinsevora, Vincent Marsiglia, Kathryn Miele, Howard Choi, Susan E. DormanAbstract:Background The tuberculin skin test (TST) has limitations for latent tuberculosis infection (LTBI) diagnosis in low-prevalence settings. Previously, all TST-positive individuals referred from the community to Baltimore City Health Department (BCHD) were offered LTBI treatment, after active TB was excluded. In 2010, BCHD introduced adjunctive QuantiFERON-TB Gold In-Tube (QFT-GIT) testing for TST-positive referrals. We evaluated costs and cost-effectiveness of this new diagnostic algorithm.
-
programmatic impact of quantiferon tb gold in tube implementation on latent tuberculosis diagnosis and treatment in a Public Health Clinic
PLOS ONE, 2012Co-Authors: Maunank Shah, Danielle Dipietro, Adena Greenbaum, Sherry Ketemepi, Maria Martinsevora, Vincent Marsiglia, Susan E. DormanAbstract:Background QuantiFERON-TB Gold In-Tube (QFT-GIT) is considered an alternative to the tuberculin skin test (TST) for the diagnosis of tuberculosis (TB) infection, but the programmatic impact of QFT-GIT implementation is largely unknown. In March, 2010, the Baltimore City Health Department (BCHD) introduced routine QFT-GIT testing for individuals referred to the TB program for suspected latent TB infection (LTBI).
Adena Greenbaum - One of the best experts on this subject based on the ideXlab platform.
-
Public Health Clinic based hepatitis c treatment
American Journal of Preventive Medicine, 2020Co-Authors: Amanda Rosecrans, Adena Greenbaum, Aneesha Cheedalla, Sarah Rives, Lisa A Scotti, Robert Harris, Risha Irvin, Boatemaa Ntirireid, Holly T Brown, Karen E AlstonAbstract:Introduction The availability of safe, effective treatments for hepatitis C virus infection has led to a call for the elimination of hepatitis C, but barriers to care persist. Methods In July 2015, the Baltimore City Health Department sexual Health Clinics began on-site hepatitis C virus treatment. Investigators conducted a retrospective evaluation of the first 2.5 years of this program. Data were extracted from the medical record through June 2019, and data analysis was completed in September 2019. Results Between July 2015 and December 2017, a total of 560 patients infected with hepatitis C virus accessed care at the Baltimore City Health Department sexual Health Clinics. Of these patients, 423 (75.5%) were scheduled for hepatitis C virus evaluation at the Clinics, 347 (62.0%) attended their evaluation appointment, 266 (47.5%) were prescribed treatment, 227 (40.5%) initiated treatment, and 199 (35.5%) achieved sustained virologic response. Older age was independently associated with hepatitis C virus evaluation appointment attendance (aged 40–59 years: AOR=3.64, 95% CI=1.88, 7.06; aged ≥60 years: AOR=5.61, 95% CI=2.58, 12.21) compared with those aged 20–39 years. Among those who attended hepatitis C virus evaluation appointments, advanced liver disease was independently and positively associated with treatment initiation (AOR=11.89, 95% CI=6.35, 22.25). Conversely, illicit substance use in the past 12 months was negatively associated with hepatitis C virus treatment initiation (AOR=0.49, 95% CI=0.25, 0.96). Conclusions The integration of hepatitis C virus testing and on-site treatment in Public sexual Health Clinics is an innovative approach to improve access to hepatitis C virus treatment for medically underserved populations.
-
programmatic impact of quantiferon tb gold in tube implementation on latent tuberculosis diagnosis and treatment in a Public Health Clinic
PLOS ONE, 2012Co-Authors: Maunank Shah, Danielle Dipietro, Adena Greenbaum, Sherry Ketemepi, Maria Martinsevora, Vincent Marsiglia, Susan E. DormanAbstract:Background QuantiFERON-TB Gold In-Tube (QFT-GIT) is considered an alternative to the tuberculin skin test (TST) for the diagnosis of tuberculosis (TB) infection, but the programmatic impact of QFT-GIT implementation is largely unknown. In March, 2010, the Baltimore City Health Department (BCHD) introduced routine QFT-GIT testing for individuals referred to the TB program for suspected latent TB infection (LTBI).